Statin use after acute myocardial infarction: A nationwide study in Denmark

British Journal of Clinical Pharmacology

Volumn 60, Issue 2, 2005, Pages 150-158

  Rasmussen, Jeppe N ^a,b   Gislason, Gunnar H ^a,c   Abildstrom, Steen Z ^a   Rasmussen, Soren ^a   Gustafsson, Ida ^c   Buch, Pernille ^a,c   Friberg, Jens ^c   Køber, Lars ^d   Torp Pedersen, Christian ^c   Madsen, Mette ^a   Stender, Steen ^b  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c BISPEBJERG HOSPITAL   (Denmark)

^d Rigshospitalet   (Denmark)

Author keywords

Acute myocardial infarction; Drug prescription; Epidemiology; Secondary prevention; Statins

Indexed keywords

ANTIDIABETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOOP DIURETIC AGENT;

ACUTE HEART INFARCTION; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DENMARK; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PRESCRIPTION; PRIORITY JOURNAL; REGISTER; SEX RATIO;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; AMBULATORY CARE; DENMARK; FEMALE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POPULATION SURVEILLANCE; PRAVASTATIN; PYRROLES; REGISTRIES; SEX DISTRIBUTION; SIMVASTATIN;

EID: 23044509719     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2005.02408.x     Document Type: Article

References (36)

1. Pedersen TR, Kjekshus J, Berg K, et al. Randomized Trial of Cholesterol-Lowering in 4444 Patients with Coronary-Heart-Disease - the Scandinavian Simvastatin Survival Study Group (4S). Lancet 1994; 344: 1383-9.
2. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnold JM, Wunn CC, Davies BR, Braunwald E. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med 1996; 335: 1001-9.
3. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998; 339: 1349-57.
4. MRC/BHF. Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360: 7-22.
5. LaRosa JC, He J, Vupputuri S. Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials JAMA 1999; 282: 2340-6.
6. MRC/BHF. Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 2003; 361: 2005-16.
7. Pyorala K, Pedersen TR, Kjekshus J, Faergeman O, Olsson AG, Thorgeirsson G. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care 1997; 20: 614-20.
8. Shepherd J, Blauw GJ, Murphy MB, Bollen ELEM, Buckley BM, Cobbe SM, Ford I, Gaw A, Hyland M, Jukema JW. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. The Lancet 2002; 360: 1623-30.
9. Williams MA, Fleg JL, Ades PA, Chaitman BR, Miller NH, Mohiuddin SM, Ockene IS, Taylor CB, Wenger NK. Secondary prevention of coronary heart disease in the elderly (with emphasis on patients ≥75 years of age): An American Heart Association Scientific Statement From the Council on Clinical Cardiology Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention. Circulation 2002; 105: 1735-43.
10. Walsh JME, Pignone M. Drug treatment of hyperlipidemia in women. JAMA 2004; 291: 2243-52.
11. Kotseva K, Wood D, De Backer G, De Bacquer D, Pyorala K, Keil U, Sans S, Ambrosio GB, Amouyel P, Cokkinos D, Deckers JW, Erhardt L, Graham I, Gutzwiller F, Keber I, Keil U, Lehto S, Ostor E, Pajak A, Sans S, Simon J, Turk J, Wood D, Wood DA, Schofield B, Bowker T, Ingham J, McLennan N, Kotseva K, Gollapalli M, Valay R, De Backer G, De Bacquer D, James D, Mackness M, Simon J, Linhartova K, Hafman P, Mayer O, Rosolova H, Bocek F, Hrncarek M, Lupinek P, Marek T, Plaskova M, Skodova Z, Cifkova R, Lehto S, Lehto R, Kemppainen A, Koukkunen H, Luukkonen J, Puhakka M, Karkkainen K, Savolainen K, Amouyel P, Montaye M, Lemaire B, Danet S, Domanievicz R, Lenoir M, Beauchant S, Dusart A, Bonte F, Fievet N, Poissonnier L, Ledoux P, Marecaux N, Steclebout C, Keil U, Liese A, Broxtermann U, Heimbach M, Heidrich J, Kalic M, Breithardt G, Enbergs A, Kerber S, Scheld H, Roeder N, Kleine-Katthofer P, Assmann G, Ostor E, Borbas S, Podmaniczky M, Ruzsanyi T, Janosi A, Belatiny-Kenez A, Bradak A, Adam Z, Barczy G, Birtalan K, Gallai I, Ambrosio GB, Leprotti C, Zardini P, Rossi L, Gallo A, Tavella D, Stritoni P, Pedrocco A, Perissinotto F, Vanuzzo D, Pilotto L, Deckers JW, Post F, Jansen C, Veerhoek M, Boer A, Stockx E, van de Berg R, Remme WJ, van Vliet R, Vos J, van der Knaap M, Turk J, Keber I, Marn K, Salapura V, Skof E, Span E, Sans S, Paluzie G, Perez I, Puig T, Varas C, Balana L, Lopez FN, Sanz G, Ferrer C, de Luna AB, Caralps JM, Dominguez M, Monras P, Rey M. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. Lancet 2001; 357: 995-1001.
12. Sueta CA, Massing MW, Chowdhury M, Biggs DP, Simpson RJ Jr. Undertreatment of hyperlipidemia in patients with coronary artery disease and heart failure. J Card Fail 2003; 9: 36-41.
13. Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999; 46: 263-8.
14. Urbach DR, Baxter NN. Does it matter what a hospital is 'high volume' for? Specificity of hospital volume-outcome associations for surgical procedures: analysis of administrative data. BMJ, doi: 10.1136/bmj.38030.642963. AE (published 12 March 2004).
15. Kanstrup H, Lassen JF, Heickendorff L, Lauritzen T, Larsen ML. Quality of lipid-lowering therapy in patients with ischaemic heart disease: a register-based study in 3477 patients. J Intern Med 2004; 255: 367-72.
16. Larsen J, Andersen M, Bjerrum L, Kragstrup J, Gram LF. Insufficient use of lipid-lowering drugs and measurement of serum cholesterol among patients with a history of myocardial infarction. J Cardiovasc Risk 2003; 10: 61-4.
17. Reid FDA, Cook DG, Whincup PH. Use of statins in the secondary prevention of coronary heart disease: is treatment equitable? Heart 2002; 88: 15-9.
18. Riahi S, Fonager K, Toft E, Hvilsted-Rasmussen Lars, Bendsen Jorgen, Paasker Johnsen Soren, Toft Sorensen Henrik. Use of lipid-lowering drugs during 1991-98 in Northern Jutland, Denmark. Br J Clin Pharmacol 2001; 52: 307-11.
19. Grundy SM, Cleeman JI, Merz CNB, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ. Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation 2004; 110: 227-39.
20. Andersen K, Lolk A, Nielsen H, Kragh-Sorensen P. Prevalence and incidence of dementia in Denmark. The Odense study. Ugeskr Laeger 2000; 162: 4386-90.
21. Ko DT, Mamdani M, Alter DA. Lipid-lowering therapy with statins in high-risk elderly patients: the treatment-risk paradox. JAMA 2004, 291, 1864-70.
22. Feely J, McGettigan P, Kelly A. Growth in use of statins after trials is not targeted to most appropriate patients. Clin Pharmacol Therapeutics 2000; 67: 438-41.
23. Savoie I, Kazanjian A. Utilization of lipid-lowering drugs in men and women: a reflection of the research evidence? J Clin Epidemiol 2002; 55: 95-101.
24. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction. N Engl J Med 1998; 339: 229-34.
25. Horwich TB, Maclellan WR, Fonarow GC. Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure. J Am Coll Cardiol 2004; 43: 642-8.
26. Segal R, Pitt B, Wilson PP, Sharma D, Bradstreet DC, Ikeda LS. Effects of HMG-COA reductase inhibitors (statins) in patients with heart failure (Abstract). European J Heart Failure 2000; 2(Suppl 1): 96.
27. Fonarow GC, Ballantyne CM. In-hospital initiation of lipid-lowering therapy for patients with coronary heart disease: the time is now. Circulation 2001; 103: 2768-70.
28. Stenestrand U, Wallentin L. Early statin treatment following acute myocardial infarction and 1-year survival. JAMA 2001; 285: 430-6.
29. Schwartz GG, Olsson AG, Ezekowitz MD, Ganz P, Oliver MF, Waters D, Zeiher A, Chaitman BR, Leslie S, Stern T. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 2001; 285: 1711-8.
30. Muhlestein JB, Horne BD, Bair TL, Li Q, Madsen TE, Pearson RR, Anderson JL Usefulness of in-hospital prescription of statin agents after angiographic diagnosis of coronary artery disease in improving continued compliance and reduced mortality. Am J Cardiol 2001; 87: 257-61.
31. Madsen M, Davidsen M, Rasmussen S, Abildstrom SZ, Osler M. The validity of the diagnosis of acute myocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry. J Clin Epidemiol 2003; 56: 124-30.
32. Drivsholm TB, Frederiksen K, de Fine ON, Odegaard B, Kristensen JK. The prevalence of diabetes in Denmark. Development of a method for a registry-based assessment. Ugeskr Laeger 2003; 165: 2887-91.
33. Kober L, Torp-Pedersen C. Clinical characteristics and mortality of patients screened for entry into the Trandolapril Cardiac Evaluation (TRACE) study. Am J Cardiol 1995; 76: 1-5.
34. Gaist D, Sorensen HT, Hallas J. The Danish prescription registries. Dan Med Bull 1997; 44: 445-8.
35. West SL, Savitz DA, Koch G, Strom BL, Guess HA, Hartzema A. Recall accuracy for prescription medications: self-report compared with database information. Am J Epidemiol 1995; 142: 1103-12.
36. Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, Joyal SV, Hill KA, Pfeffer MA, Skene AM. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004; 350: 1495-504.